Background illustration for clinical trials search

Paid Clinical Trials Saint Paul

Discover 1,003 paid clinical trials in Saint Paul, Minnesota. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

Fluid Management of Acute Decompensated Heart Failure Subjects Treated With Reprieve System (FASTR-II) (IDE-G210258)

for
Acute Decompensated Heart Failure
Location: Minneapolis MN, Omaha NE, Grand Rapids MI,
Sponsor: Reprieve Cardiovascular, Inc

Sex: All

Age: 22+

Code: NCT06898515

Phase3, Recruiting

CardiolRx in Recurrent Pericarditis (MAVERIC Phase-3)

for
Recurrent Pericarditis
Location: Minneapolis MN, Rochester MN, Chicago IL, Cleveland OH,
Sponsor: Cardiol Therapeutics Inc.

Sex: All

Age: 18+

Code: NCT06708299

Phase3, Recruiting

A Study of ICP-192 in Patients With Advanced Solid Tumors

for
Advanced Solid Tumors, Urothelial Carcinoma, Cholangiocarcinoma
Location: Minneapolis MN, Columbus OH, Aurora CO, Bronx NY,
Sponsor: Beijing InnoCare Pharma Tech Co., Ltd.

Sex: All

Age: 18+

Code: NCT04565275

Phase1, Phase2, Recruiting

Study of ORIC-944 in Patients With Metastatic Prostate Cancer

for
Metastatic Prostate Cancer
Location: Minneapolis MN, Lake Barrington IL,
Sponsor: ORIC Pharmaceuticals

Sex: Male

Age: 18+

Code: NCT05413421

Phase1, Recruiting

A Study of Avutometinib (VS-6766) + Defactinib (VS-6063) in Recurrent Low-Grade Serous Ovarian Cancer

for
Low Grade Serous Ovarian Cancer
Location: Minneapolis MN, Evanston IL, St Louis MO, Detroit MI,
Sponsor: Verastem, Inc.

Sex: Female

Age: 18+

Code: NCT06072781

Phase3, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

Study of AU-007, A Monoclonal Antibody That Binds to IL-2 and Inhibits IL-2Rα Binding, in Patients With Unresectable Locally Advanced or Metastatic Cancer

for
Advanced Solid Tumor, Metastatic Cancer, Cutaneous Melanoma,
Location: Minneapolis MN, Grand Rapids MI, St Louis MO,
Sponsor: Aulos Bioscience, Inc.

Sex: All

Age: 18+

Code: NCT05267626

Phase1, Phase2, Recruiting

Outpatient Administration of Teclistamab or Talquetamab for Multiple Myeloma

for
Multiple Myeloma
Location: Minneapolis MN, Cincinnati OH, Nashville TN, Denver CO,
Sponsor: SCRI Development Innovations, LLC

Sex: All

Age: 18+

Code: NCT05972135

Phase2, Recruiting

Study of Navtemadlin as Maintenance Therapy in TP53WT Advanced or Recurrent Endometrial Cancer

for
Endometrial Cancer
Location: Minneapolis MN, Hinsdale IL, Saint Louis MO,
Sponsor: Kartos Therapeutics, Inc.

Sex: Female

Age: 18+

Code: NCT05797831

Phase2, Phase3, Recruiting

A Study of INCB123667 in Participants With Platinum-Resistant Ovarian Cancer With Cyclin E1 Overexpression

for
Ovarian Cancer
Location: Minneapolis MN, Iowa City IA, Milwaukee WI, Omaha NE,
Sponsor: Incyte Corporation

Sex: Female

Age: 18 - 70+

Code: NCT07023627

Phase2, Recruiting

A Study to Compare Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) Versus Pembrolizumab Alone as Treatment in Participants With Mismatch Repair Proficient Endometrial Cancer (MK-2870-033/TroFuse-033/GOG-3119/ENGOT-en29)

for
Endometrial Cancer
Location: Minneapolis MN, Chicago IL, Winnipeg, Sault Ste. Marie,
Sponsor: Merck Sharp & Dohme LLC

Sex: Female

Age: 18+

Code: NCT06952504

Phase3, Recruiting

Study of Narazaciclib (ON 123300) Plus Letrozole in Endometrial Cancer and Other Gynecologic Malignancies

for
Endometrioid Endometrial Cancer
Location: Minneapolis MN, Dallas TX, Fort Worth TX, Greenville SC,
Sponsor: Traws Pharma, Inc.

Sex: Female

Age: 18+

Code: NCT05705505

Phase1, Phase2, Recruiting

MammaPrint, BluePrint, and Full-genome Data Linked With Clinical Data to Evaluate New Gene EXpression Profiles

for
Breast Cancer
Location: Minneapolis MN, Milwaukee WI, Thunder Bay,
Sponsor: Agendia

Sex: All

Age: 18+

Code: NCT03053193

Recruiting

Study of Trastuzumab Deruxtecan With Bevacizumab Versus Bevacizumab Monotherapy for First-line Maintenance in HER2-Expressing Ovarian Cancer (DESTINY-Ovarian01)

for
Ovarian Cancer
Location: Minneapolis MN, Sioux Falls SD, Evanston IL,
Sponsor: Daiichi Sankyo

Sex: Female

Age: 18+

Code: NCT06819007

Phase3, Recruiting

A Study to Evaluate Mezigdomide, Bortezomib and Dexamethasone (MEZIVd) Versus Pomalidomide, Bortezomib and Dexamethasone (PVd) in Participants With Relapsed or Refractory Multiple Myeloma (RRMM)

for
Relapsed or Refractory Multiple Myeloma
Location: Minneapolis MN, Westwood KS, Ann Arbor MI, Detroit MI,
Sponsor: Celgene

Sex: All

Age: 18+

Code: NCT05519085

Phase3, Recruiting

Phase IIIb Study of Ribociclib + ET in Early Breast Cancer

for
Early Breast Cancer
Location: Minneapolis MN, Sioux Falls SD, Omaha NE, Hinsdale IL,
Sponsor: Novartis Pharmaceuticals

Sex: All

Age: 18 - 70+

Code: NCT05827081

Phase3, Recruiting

Racial and Economic Disparities and Unmet Needs in Patients With Severe Aortic Valvular Disease

for
Disparities in Treatment of Aortic Valve Stenosis,
Location: Minneapolis MN
Sponsor: Minneapolis Heart Institute Foundation

Sex: All

Age: 18+

Code: NCT04525937

Recruiting

Endovascular AAA Intervention Using the GORE® EXCLUDER® Conformable AAA Endoprosthesis or Iliac Branch Endoprosthesis

for
AAA - Abdominal Aortic Aneurysm
Location: Minneapolis MN, Rochester MN, Milwaukee WI, Evanston IL,
Sponsor: W.L.Gore & Associates

Sex: All

Age: 18+

Code: NCT06218875

Recruiting

A Study to Assess Efficacy and Safety of Pembrolizumab With or Without Sacituzumab Tirumotecan (MK- 2870) in Adult Participants With Resectable Non Small Cell Lung Cancer (NSCLC) Not Achieving Pathological Complete Response (pCR) (MK-2870-019)

for
Non Small Cell Lung Cancer
Location: Minneapolis MN, Rochester MN, Sioux Falls SD, Fargo ND,
Sponsor: Merck Sharp & Dohme LLC

Sex: All

Age: 18+

Code: NCT06312137

Phase3, Recruiting

The TRICURE EFS Study

for
Tricuspid Valve Regurgitation, Heart Valve Diseases,
Location: Minneapolis MN, Chicago IL, Ann Arbor MI, Cincinnati OH,
Sponsor: TRiCares

Sex: All

Age: 18+

Code: NCT06506942

Recruiting

A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence

for
Breast Cancer
Location: Minneapolis MN, Saint Louis Park MN, Mankato MN,
Sponsor: Stemline Therapeutics, Inc.

Sex: All

Age: 18+

Code: NCT06492616

Phase3, Recruiting